Skip to main navigation
logo
  • Home
  • Overview
  • News & Events
    • Press Releases
    • Events and Presentations
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Financials
    • SEC Filings
    • Annual Reports
    • Quarterly Releases
  • Governance
    • Governance Overview
    • Board of Directors
    • Management
    • Committee Composition
  • IR Resources
    • Email Alerts
    • Contact IR

Press Releases

Press Releases

May 28, 2020
Athira Pharma to Present at Jefferies Virtual Global Healthcare Conference
December 9, 2019
Athira Pharma Presents Positive Data for NDX-1017 in Alzheimer's Patients at 2019 Clinical Trials on Alzheimer's Disease (CTAD) Conference
November 20, 2019
Athira Pharma to Present Phase 1 Data for NDX-1017 in Oral Presentation at 2019 Clinical Trials on Alzheimer's Disease (CTAD) Conference
October 2, 2019
Athira Pharma Announces Completion of Phase 1b Clinical Trial of NDX-1017 in Alzheimer's Patients
July 16, 2019
Athira Pharma Presents Preliminary Results from Phase 1 Trial of NDX-1017 at Alzheimer's Association International Conference 2019 (AAIC)
July 11, 2019
Athira Pharma Announces Appointment of Mark Litton as Chief Operating Officer
July 1, 2019
Athira Pharma's Leen Kawas Selected as Young Leader by French-American Foundation
May 1, 2019
Athira Pharma Announces Appointment of Dr. Hans J. Moebius as Chief Medical Officer
April 11, 2019
M3 Biotechnology Announces Name Change to Athira Pharma, Inc.

Pagination

  • First page « first
  • Previous page ‹ previous
  • …
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Current page 14
Displaying 131 - 139 of 139
< SIGN UP FOR EMAIL ALERTS
CONTACT IR

Athira Pharma, Inc.
18706 North Creek Parkway
Suite 104
Bothell, WA 98011

info@athira.com

FCOI Policy

Privacy Policy

© Athira Pharma, Inc. All rights reserved.